The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
Open accessAbstract
Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the use of anacardic acid, an inhibitor of protein SUMOylation, 16 abrogated pksC E. coliinduced senescence (unpublished data).”
From The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment (2014) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,711
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006
SUMO‐1 modification activates the transcriptional response of p53
Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Midgley, C., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 597
Self-citationSmall Molecule Modulators of Histone Acetyltransferase p300
Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 518
Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1
Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., & Sal, G. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6462 · Cited by 512
Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics
Yang, Y., Kitagaki, J., Dai, R., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0568 · Cited by 442
Regulation of SUMOylation by Reversible Oxidation of SUMO Conjugating Enzymes
Bossis, G., & Melchior, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.12.019 · Cited by 406
The emerging field of dynamic lysine methylation of non-histone proteins
Huang, J. L., & Berger, S. L. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.012 · Cited by 296
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 360
The SUMO Pathway in Hematomalignancies and Their Response to Therapies
Boulanger, M., Paolillo, R., Piechaczyk, M., & Bossis, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163895 · Cited by 43
Maurel, C., Chami, A. A., Thépault, R., Marouillat, S., Blasco, H., Corcia, P., Andres, C. R., & Vourc’h, P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01810-7 · Cited by 43
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 43
SUMOylation occurs in acute kidney injury and plays a cytoprotective role
Guo, C., Wei, Q., Su, Y., & Dong, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.013 · Cited by 42
Current Status of SUMOylation Inhibitors
Brackett, C. M., & Blagg, B. S. J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200810135039 · Cited by 43
Dubuissez, M., Loison, I., Paget, S., Vorng, H., Yahia, S. A., Rohr, O., Tsicopoulos, A., & Leprince, D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-16 · Cited by 44
Qiu, F., Dong, C., Liu, Y., Shao, X., Huang, D., Han, Y., Wang, B., Liu, Y., Huo, R., Paulo, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.006 · Cited by 40
Prieto, M., Folci, A., & Martin, S. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0629-4 · Cited by 44
Portilho, D. M., Fernandez, J., Ringeard, M., Machado, A. K., Boulay, A., Mayer, M., Müller-Trutwin, M. C., Beignon, A., Kirchhoff, F., Nisole, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.039 · Cited by 44
Kumar, A., Ito, A., Hirohama, M., Yoshida, M., & Zhang, K. Y. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.030 · Cited by 40
Self-citationSUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells
Martinat, C., Cormier, A., Tobaly-Tapiero, J., Palmic, N., Casartelli, N., Mahboubi, B., Coggins, S. A., Buchrieser, J., Persaud, M., Diaz‐Griffero, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24802-5 · Cited by 44
Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols
Ryckewaert, L., Sacconnay, L., Carrupt, P., Nurisso, A., & Simões‐Pires, C. A. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.07.002 · Cited by 38
Chhunchha, B., Kubo, E., Fatma, N., & Singh, D. P. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.424 · Cited by 38
Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro, Una, and Zika Viruses
Campos, D., Navarro, S., Llamas-González, Y. Y., Sugasti-Salazar, M., & González, J. (2020) · Viruses · doi:10.3390/v12040449 · Cited by 38
Zhou, G., Yao, X., Tang, Y., Qian, D., Su, S., Li, Z., Jin, C. H., Qin, Y., & Duan, J. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.02.116 · Cited by 38
Wu, R., Fang, J., Liu, M., Jun, A., Liu, J., Chen, W., Li, J., Ma, G., Zhang, Z., Zhang, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012338 · Cited by 36
The SUMO pathway in pancreatic cancer: insights and inhibition
Schneeweis, C., Hassan, Z., Schick, M., Keller, U. B., & Schneider, G. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01119-6 · Cited by 36
Ramírez-Jarquín, U. N., Sharma, M., Zhou, W., Shahani, N., & Subramaniam, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107187119 · Cited by 36
Lee, E. J., Hwang, I., Lee, J. Y., Park, J. N., Kim, K. C., Kim, G.-H., Kang, C.-M., Kim, I., Lee, S.-Y., & Kim, H.-S. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.015 · Cited by 34
Gerstmeier, J., Seegers, J., Witt, F., Waltenberger, B., Temml, V., Rollinger, J. M., Stuppner, H., Koeberle, A., Schuster, D., & Werz, O. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00797 · Cited by 35
Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer’s Disease
Marcelli, S., Ficulle, E., Iannuzzi, F., Kövari, E., Nisticò, R., & Feligioni, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0176-9 · Cited by 38
Zhang, Z.-B., Ruan, C., Chen, D.-R., Zhang, K., Chen, Y., & Gao, P. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.001 · Cited by 34
Huang, C., Kuo, C., Pai, P., Ho, T.-J., Lin, Y., Chen, R., Tsai, F. C., Padma, V. V., Kuo, W., & Huang, C. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.102 · Cited by 34
SUMOylation determines turnover and localization of nephrin at the plasma membrane
Tossidou, I., Himmelseher, E., Teng, B., Haller, H. G., & Schiffer, M. (2014) · Kidney International · doi:10.1038/ki.2014.198 · Cited by 34
Ginkgolic Acid Protects against Aβ-Induced Synaptic Dysfunction in the Hippocampus
Mango, D., Weisz, F., & Nisticò, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00401 · Cited by 33
Feitosa, W. B., Hwang, K., & Morris, P. L. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.12.011 · Cited by 33
Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration
Amanullah, A., Upadhyay, A., Joshi, V., Mishra, R., Jana, N. R., & Mishra, A. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.005 · Cited by 34
Crosstalk between SUMOylation and other post-translational modifications in breast cancer
Wei, B., Yang, F., Yu, L., & Qiu, C. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00624-3 · Cited by 36
SUMOylation, aging and autophagy in neurodegeneration
Vijayakumaran, S., & Pountney, D. L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.015 · Cited by 32
da Silva, S. R., Paiva, S.-L., Lukkarila, J. L., & Gunning, P. T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301420b · Cited by 33
Chanda, A., Sarkar, A., & Bonni, S. (2018) · Cancers · doi:10.3390/cancers10080264 · Cited by 31
Molfetta, R., Zingoni, A., Santoni, A., & Paolini, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02557 · Cited by 26
Evidence that Ginkgo Biloba could use in the influenza and coronavirus COVID-19 infections
Ibrahim, M. A., Ramadan, H. H., & Mohammed, R. N. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0310 · Cited by 33
SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer
Wu, W., & Huang, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122085 · Cited by 30
The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation
Meredith, L. J., Wang, C., Nascimento, L. A., Liu, R., Wang, L., & Yang, W. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25288 · Cited by 30
Wang, W., Wang, M., Ruan, Y., Tan, J., Wang, H., Yang, T., Li, J., & Zhou, Q. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04178 · Cited by 29
Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
Bentz, G. L., Lowrey, A. J., Horne, D. C., Nguyen, V., Satterfield, A. R., Ross, T., Harrod, A. E., Uchakina, O. N., & McKallip, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217578 · Cited by 31
ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation
Kobayashi, T., Wang, J., Al‐Ahmadie, H. A., & Abate-Shen, C. T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0207 · Cited by 28
1 H NMR-based metabolomics study of liver damage induced by ginkgolic acid (15:1) in mice
Jiang, L., Si, Z.-H., Li, M., Zhao, H., Fu, Y.-H., Xing, Y.-X., Wei, H., Ruan, L., Li, P.-M., & Wang, J. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.12.033 · Cited by 28
Chhunchha, B., Kubo, E., Singh, P., & Singh, D. P. (2018) · Aging · doi:10.18632/aging.101547 · Cited by 28
Bhutta, M., Shechter, O., Gallo, E. S., Martin, S., Jones, E., Doncel, G. F., & Borenstein, R. (2021) · Viruses · doi:10.3390/v13010086 · Cited by 28
Liu, D., Li, Z., Yang, Z., Ma, J., & Mai, S. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109394 · Cited by 28
Boag, M. K., Roberts, A., Uversky, V. N., Ma, L., Richardson, D. R., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042378 · Cited by 31
Zhao, Q., Ma, Y., Li, Z., Zhang, K., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8835714 · Cited by 28
SUMOylation in Glioblastoma: A Novel Therapeutic Target
Fox, B. M., Janssen, A., Estévez-Ordoñez, D., Gessler, F. A., Vicario, N., Chagoya, G., Elsayed, G., Sotoudeh, H., Stetler, W. R., Friedman, G. K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081853 · Cited by 27
Qian, Y., Peng, Y., Shang, E., Zhao, M., Liang, Y., Zhu, Z., Tao, J., Su, S., Guo, S., & Duan, J. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.020 · Cited by 26
The SUMO Conjugation Complex Self-Assembles into Nuclear Bodies Independent of SIZ1 and COP1
Mazur, M. J., Kwaaitaal, M. A. C. J., Arroyo‐Mateos, M., Maio, F., Kini, K. R., Prins, M., & van den Burg, H. A. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.00910 · Cited by 26
SUMOylation mediates CtIP’s functions in DNA end resection and replication fork protection
Locke, A. J., Hossain, L., McCrostie, G., Ronato, D. A., Fitieh, A. M., Rafique, T. A., Mashayekhi, F., Motamedi, M., Masson, J., & Ismail, I. H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1232 · Cited by 27
Kim, I., Lee, J.-H., Kim, S., Heo, C.-K., Kim, R.-K., & Cho, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02303-x · Cited by 27
SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes
Hsu, C.-Y., Yeh, L., Fu, S., Chien, M., Liu, Y.-W., Miaw, S., Chang, D., & Sytwu, H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98786 · Cited by 26
Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Cheng, X., Yang, W., Lin, W., & Mei, F. C. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000784 · Cited by 25
Li, Y., Zhang, J., Li, S., Guo, C., Li, Q., Zhang, X., Li, M., & Mi, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.687912 · Cited by 26
SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone
Gomarasca, M., Lombardi, G., & Maroni, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.889002 · Cited by 26
Hofmann, S., Plank, V., Groitl, P., Skvorc, N., Hofmann, K., Luther, J., Ko, C., Zimmerman, P., Bruss, V., Stadler, D., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00446-23 · Cited by 24
The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle
Hundt, J., Li, Z., & Liu, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117514 · Cited by 25
Liu, H., Li, J., Lü, D., Li, J., Liu, M., He, Y., Williams, B. O., Li, J., & Yang, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-20244-0 · Cited by 25
Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer’s disease
Wan, L., Yang, F., Yin, A., Luo, Y., Yi, L. I. U., Liu, F., Wang, J., Liu, R., & Wang, X. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01448-0 · Cited by 26
Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors
Kumar, A., Ito, A., Hirohama, M., Yoshida, M., & Zhang, K. Y. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.022 · Cited by 23
Self-citationSumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis
Joung, H., Kwon, S., Kim, K. H., Lee, Y.-G., Shin, S., Kwon, D., Lee, Y.-U., Kook, T., Choe, N., Kim, J. C., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.236 · Cited by 24
How Does SUMO Participate in Spindle Organization?
Abrieu, A., & Liakopoulos, D. (2019) · Cells · doi:10.3390/cells8080801 · Cited by 24
Wang, D., Zhu, H., Li, M., Song, X., Yan, H., Yu, J., & Wang, X. D. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.09.034 · Cited by 23
Benoit, Y. D., Mitchell, R. R., Wang, W., Orlando, L., Boyd, A. L., Tanasijevic, B., Aslostovar, L., Shapovalova, Z., Doyle, M., Bergin, C. J., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.014 · Cited by 24
The role of SUMOylation in biomolecular condensate dynamics and protein localization
Gutierrez-Morton, E., & Wang, Y. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100199 · Cited by 24
Yuan, H., Lu, Y., Chan, Y.-T., Zhang, C., Wang, N., & Feng, Y. (2021) · Cancers · doi:10.3390/cancers13225700 · Cited by 22
Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
Gâtel, P., Piechaczyk, M., & Bossis, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_2 · Cited by 23
Development of a High-Throughput Screen to Detect Inhibitors of TRPS1 Sumoylation
Brandt, M. A., Szewczuk, L. M., Zhang, H., Hong, X., McCormick, P. M., Lewis, T. S., Graham, T. I., Hung, S., Harper-Jones, A. D., Kerrigan, J. J., et al. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2012.501 · Cited by 22
Inhibition of p53 deSUMOylation Exacerbates Puromycin Aminonucleoside-Induced Apoptosis in Podocytes
Wang, L., Zhu, J., Fang, M., Zhang, T., Xie, H., Wang, N., Shen, N., Guo, H., Fu, B., & Lin, H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121314 · Cited by 22
Zlotkowski, K., Hewitt, W. M., Yan, P., Bokesch, H. R., Peach, M. L., Nicklaus, M. C., O’Keefe, B. R., McMahon, J. B., Gustafson, K. R., & Schneekloth, J. S. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b00496 · Cited by 22
Targeting α-synuclein post-translational modifications in Parkinson’s disease
Canever, J. B., Soares, E. S., de Avelar, N. C. P., & Cimarosti, H. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114204 · Cited by 22
The SUMOylation and ubiquitination crosstalk in cancer
Li, K., Xia, Y., He, J., Wang, J., Li, J., Ye, M., & Jin, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05310-z · Cited by 20
Protein modification in neurodegenerative diseases
Ramazi, S., Dadzadi, M., Darvazi, M., Seddigh, N., & Allahverdi, A. (2024) · MedComm · doi:10.1002/mco2.674 · Cited by 25
Differential Nanos 2 protein stability results in selective germ cell accumulation in the sea urchin
Oulhen, N., & Wessel, G. M. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.07.007 · Cited by 21
An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
Marcelli, S., Ficulle, E., Piccolo, L., Corbo, M., & Feligioni, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.023 · Cited by 21
Chen, C.-F., Wang, K., Zhang, H.-F., Zhou, H., Chen, Y.-X., & Min, W. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01089 · Cited by 19
Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors
Brackett, C. M., García‐Casas, A., Castillo‐Lluva, S., & Blagg, B. S. J. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00353 · Cited by 20
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation
Zhou, H., Deng, N., Li, Y., Hu, X., Xue, Y., Jia, S., Zheng, C., Gao, S., Wu, H., & Li, K. (2024) · Theranostics · doi:10.7150/thno.97162 · Cited by 25
Zhang, J., & Yan, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01241 · Cited by 19
SUMO modulation of protein aggregation and degradation
Feligioni, M., Marcelli, S., Knock, E., Nadeem, U., Arancio, O., & Fraser, P. E. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.4.382 · Cited by 19
SUMOylation in atherosclerosis
Liu, Y.-Z., Xiao, X., Hu, C.-T., Dai, Y., Qu, S.-L., Huang, L., & Zhang, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.033 · Cited by 19
SUMOylation in fungi: A potential target for intervention
Gupta, D., Garapati, H. S., Kakumanu, A. V. S., Shukla, R., & Mishra, K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.10.037 · Cited by 19
Dynamic regulation of HIF1Α stability by SUMO2/3 and SENP3 in the human placenta
Bhattacharjee, J., Alahari, S., Sallais, J., Tagliaferro, A., Post, M., & Caniggia, I. (2016) · Placenta · doi:10.1016/j.placenta.2016.02.002 · Cited by 18
Inhibition of CDK1 activity by sumoylation
Xiao, Y., Lucas, B., Molcho, E., Schiff, T., & Vigodner, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.051 · Cited by 18
Differential effects of SUMO1 and SUMO3 on PKR activation and stability
Maarifi, G., Asmi, F. E., Maroui, M. A., Dianoux, L., & Chelbi‐Alix, M. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-19683-6 · Cited by 18
Talin is a substrate for SUMOylation in migrating cancer cells
Huang, Z., Barker, D., Gibbins, J. M., & Dash, P. R. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.005 · Cited by 18
Guanosine modulates SUMO2/3-ylation in neurons and astrocytes via adenosine receptors
Zanella, C. A., Tasca, C. I., Henley, J. M., Wilkinson, K. A., & Cimarosti, H. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09723-0 · Cited by 18
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
Andrade, J. P. D., Lorenzen, A. W., Wu, V. T., Bogachek, M. V., Park, J. M., Gu, V. W., Sevenich, C. M., Cassady, V. C., Beck, A. C., Kulak, M. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21954 · Cited by 18
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01491-0 · Cited by 17
Rethinking Parkinson's: The role of proteostasis networks and autophagy in disease progression
Sharma, A., Mannan, A., & Singh, T. G. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104023 · Cited by 19
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents
Gabbianelli, R., Shahar, E., de Simone, G., Rucci, C., Bordoni, L., Feliziani, G., Zhao, F., Ferrati, M., Maggi, F., Spinozzi, E., et al. (2023) · Nutrients · doi:10.3390/nu15224719 · Cited by 20
Selective potentiation of alpha 1 glycine receptors by ginkgolic acid
Maleeva, G., Buldakova, S., & Bregestovski, P. D. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00064 · Cited by 17
SUMO‐Mimicking Peptides Inhibiting Protein SUMOylation
Zhao, B., Villhauer, E. B., Bhuripanyo, K., Kiyokawa, H., Schindelin, H., & Yin, J. (2014) · ChemBioChem · doi:10.1002/cbic.201402472 · Cited by 17
Feitosa, W. B., & Morris, P. L. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00038.2018 · Cited by 17
Bahnassy, S., Thangavel, H., Quttina, M., Khan, A. F., Dhanyalayam, D., Ritho, J., Karami, S., Ren, J. F., & Bawa‐Khalfe, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00649-z · Cited by 17
Subramonian, D., Chen, T.-A., Paolini, N., & Zhang, X. D. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1907509 · Cited by 17
Welch, M. A., Forster, L. A., Atlas, S. I., & Baro, D. J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00144 · Cited by 17
Choi, G. W., Lee, Y. J., Yun, M., Kang, J., & Lee, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.189 · Cited by 17
Sumoylation as an Emerging Target in Therapeutics against Cancer
Liu, S., Wang, L., Jiang, D., Wei, W., Nasir, M. F., Khan, M. S., Yousafi, Q., Liu, X., Fu, X., Li, X., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200622124134 · Cited by 16
Garcia, P., Harrod, A. E., Jha, S., Jenkins, J., Barnhill, A., Lee, H., Thompson, M., Williams, J. P., Barefield, J., McKinnon, A., et al. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105038 · Cited by 15
The Pharmacology and Toxicology of Ginkgolic Acids: Secondary Metabolites from Ginkgo biloba
Shao, Y., Chen, Y., Zhu, Q., Yi, L., Ma, Y., Zang, X., & Yao, W. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500077 · Cited by 15
Zhou, Q., Zhang, L., Chen, Z., Zhao, P.-G., Ma, Y., Yang, B., He, Q., & Ying, M. (2014) · FEBS Journal · doi:10.1111/febs.12840 · Cited by 15
Metadata
- Authors
- Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K.-I., Sodeoka, M., & Yoshida, M.
- Affiliations
- RIKEN Advanced Science Institute (JP)
- Japan Science and Technology Agency (JP)
- RIKEN (JP)
- Tokyo Denki University (JP)
- Institute of Molecular Embryology and Genetics, Kumamoto University (JP)
- Iwate University (JP)
- Corresponding author
- Ito, Akihiro
- ORCID
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 16
- Issue
- 2
- Pages
- 133-140
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1978693761
- Cited by
- 355
- References
- 23
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 25 · 2023: 23 · 2022: 21 · 2021: 27 · 2020: 28 · 2019: 27 · 2018: 31 · 2017: 30 · 2016: 23 · 2015: 20 · 2014: 31 · 2013: 9 · 2012: 6
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Chemistry & Biology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Sakura: Saitama United Cyber Repository of Academic Resources (Saitama University) (submittedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Advanced Science Institute
- Japan Science and Technology Corporation
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- ginkgolic acid, anacardic acid, protein sumoylation, SUMOylation inhibition, small molecule inhibitors, SUMO conjugation, ubiquitination, drug development
- MeSH terms
- Plant Extracts, Protein Binding, Salicylates, Structure-Activity Relationship, Plant Leaves, Ginkgo biloba, Small Ubiquitin-Related Modifier Proteins, Anacardic Acids, Small Molecule Libraries, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review